Tag: Side Effects

Methotrexate noninferior to prednisone with regard to change from baseline to week 24 in percentage of predicted forced vital capacity

7 percent of 108 healthy volunteers reported urticaria; unresolved urticaria persisted at 12 months in four participants

Some benefits include mitigation of cardiac toxicity, peripheral neuropathy, cognitive impairment, and dyspnea

Increases in hemodynamic signs seen with amphetamines, atomoxetine, lisdexamfetamine, methylphenidate, and viloxazine

PROSTOX predicts late genitourinary toxicity, yielding area under the curve of 0.76

Risks increased for peptic ulcer bleeding, uncomplicated peptic ulcer, lower GI bleeding, heart failure, HTN, CKD

Corneal toxicity not uncommon with MIRV treatment for primary gynecologic malignancies, usually resolves

Each 1-degree Celsius increase in skin temperature after dose 2 linked to 1.8-, 3.1-fold higher nAB one and six months later

Increased risk seen in association with female sex, older age, CKD stage 3 or greater, tamoxifen use

Overall, 23.2 percent of adverse events are preventable; 17.2 percent are serious